The Public's Health: Names Matter in the Opioid Epidemic | Public Health Post

A quick survey of any number of general media reports about drug use will readily find mentions of “addicts” who use opioids. Casual conversations label those who use drugs as “junkies.” We are accustomed to using language to distance ourselves from those with substance use problems, making sure we mark those who use drugs as “the other,” not like us. 
Erving Goffman, one of the giants in psychology of the twentieth century defined stigma as “The phenomenon whereby an individual with an attribute which is deeply discredited by his/her society is rejected as a result of the attribute. Stigma is a process by which the reaction of others spoils normal identity.” That is exactly what we have done with drug use and drug users. We have used nouns to label those who use drugs so that they are discredited as a result of their drug use, spoiling their normal identity. In research we had carried out nearly two decades ago, we showed that substance users feel more marginalized because of their drug use than any other self-identification.  
Little has changed in the ensuing two decades. The opioid epidemic now kills more people annually than the HIV epidemic did at its peak, the firearm epidemic at its peak, or deaths from motor vehicles at their peak. And yet, despite near-saturation media coverage of the problem, limited resources have been made available by the Trump administration to tackle the epidemic. Surely part of the challenge is our ongoing stigmatization of those who use drugs. Because those who use drugs are the other, and could not be us. Continued use of marginalizing words in mass media echo this distancing, reinforcing the abnormality of “them,” “those” who use drugs. Names have the power to separate.
But the current epidemic has taught us that we all know someone who has developed a drug problem. It seems like a small step, but using the right language, always, to talk about drug use is a step toward helpful description, toward making it clear that opioids are our collective problem and worthy of investment that can turn the tide on the epidemic of our time.

Michael Stein & Sandro Galea